AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Clin Nutr (December 3, 2008). doi:10.3945/ajcn.2008.26142
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
89/1/257    most recent
ajcn.2008.26142v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. Y.
Right arrow Articles by Kwon, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. Y.
Right arrow Articles by Kwon, O.
Agricola
Right arrow Articles by Kim, J. Y.
Right arrow Articles by Kwon, O.
© 2008 American Society for Clinical Nutrition

Cancer

Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims1,2

Ji Yeon Kim and Oran Kwon

1 From the Division of Nutrition and Functional Food Standards, Korea Food and Drug Administration, Seoul, Korea (JYK), and the Department of Nutritional Science and Food Management, Ewha Women's University, Seoul, Korea (OK).

2 Reprints not available. Address correspondence to O Kwon, Human Ecology Building 301, Ewha Women's University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul, 120-750, Korea. E-mail: orank{at}ewha.ac.kr.

ABSTRACT

Background: Numerous animal and in vitro studies provided evidence for a relation between garlic intake and cancer risk reduction. Several studies also reported an inverse association in humans. However, no claims have been made about garlic intake and cancer risk reduction with respect to food labeling.

Objective: The objective of this study was to evaluate the scientific evidence for garlic intake with respect to the risk of different types of cancer using the US Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims.

Design: Literature searches were conducted by using the Medline and EMBASE databases for the period 1955–2007 with search terms Allium sativum, vegetables, diet, and nutrition in combination with cancer, neoplasm, and individual cancers. The search was limited to human studies published in English and Korean.

Results: With the use of the US Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims, 19 human studies were identified and reviewed to evaluate the strength of the evidence that supports a relation between garlic intake and reduced risk of different cancers with respect to food labeling.

Conclusions: There was no credible evidence to support a relation between garlic intake and a reduced risk of gastric, breast, lung, or endometrial cancer. Very limited evidence supported a relation between garlic consumption and reduced risk of colon, prostate, esophageal, larynx, oral, ovary, or renal cell cancers.

Received for publication March 12, 2008. Accepted for publication August 31, 2008.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
R. S Rivlin
Can garlic reduce risk of cancer?
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 17 - 18.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by The American Society for Nutrition